Related Experiment Video
Updated: May 18, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Where EGF receptors transmit their signals
Nancy L Lill1, Nurettin Ilter Sever
1Department of Pathology and the OSU Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA. nancy.lill@osumc.edu
Targeting the earliest stages of epidermal growth factor receptor (EGFR) trafficking may effectively suppress cancer-promoting signals. This approach focuses on specific EGFR locations within the cell to optimize therapeutic strategies against receptor tyrosine kinase (RTK) driven cancers.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Therapeutics
Background:
- Receptor tyrosine kinases (RTKs), such as the epidermal growth factor receptor (EGFR), are crucial for cell signaling but can drive cancer when overactive.
- Understanding the molecular mechanisms that regulate RTK signaling and their potential defects in tumors is essential for developing effective cancer therapies.
- The trafficking pathway of EGFR influences its signaling amplitude and downstream effects.
Purpose of the Study:
- To investigate the molecular mechanisms controlling epidermal growth factor receptor (EGFR) signaling.
- To determine if these regulatory mechanisms are defective in cancer cells.
- To explore the potential of targeting specific EGFR trafficking stages for cancer therapy.
Main Methods:
- Mechanistic studies focusing on the epidermal growth factor receptor (EGFR) as a prototypical RTK.
- Analysis of EGFR signaling and transcriptional responses at different stages of its degradative trafficking pathway (cell surface, endosomes, lysosomes).
- Investigating the role of endosomal sorting complex required for transport (ESCRT) complexes in EGFR regulation.
Main Results:
- EGFRs at the plasma membrane are responsible for the majority of the global transcriptional response to EGF.
- EGFRs between internalization and early endosome fusion stages are associated with enriched expression of cancer-related transcripts.
- EGFRs at later trafficking stages, regulated by ESCRT complexes, do not significantly contribute to the EGFR-mediated transcriptional response.
Conclusions:
- The location of EGFR within the degradative trafficking pathway dictates its contribution to oncogenic signaling.
- Targeting EGFRs at the earliest stages of their trafficking pathway, from the cell surface to early endosomes, may be the most effective therapeutic strategy.
- Restoring normal regulatory pathways by targeting specific EGFR trafficking sites holds promise for cancer treatment.
Related Concept Videos
Amplifying Signals via Second Messengers
Mitogens and the Cell Cycle
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

